NCT04245033View on ClinicalTrials.gov

Evaluation of the Implementation and Effectiveness of Intermittent Preventive Treatment for Malaria Using Dihydroartemisinin-piperaquine on Reducing Malaria Burden in School Aged Children in Tanzania

PHASE4CompletedINTERVENTIONAL
Enrollment

4,100

Participants

Timeline

Start Date

July 20, 2020

Primary Completion Date

May 31, 2021

Study Completion Date

June 28, 2021

Conditions
Malaria
Interventions
DRUG

Dihydroartemisinin-Piperaquine (DP)

Dihydroartemisinin-Piperaquine (DP) for intermittent preventive treatment of malaria in school children (IPTsc).

Trial Locations (1)

Unknown

Handeni Town Council, Handeni and Kilindi Districts, Tanga

All Listed Sponsors
collaborator

National Malaria Control Program, Tanzania

UNKNOWN

lead

National Institute for Medical Research, Tanzania

OTHER_GOV

NCT04245033 - Evaluation of the Implementation and Effectiveness of Intermittent Preventive Treatment for Malaria Using Dihydroartemisinin-piperaquine on Reducing Malaria Burden in School Aged Children in Tanzania | Biotech Hunter | Biotech Hunter